Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by hmmmmmmmmon Sep 07, 2023 4:13pm
115 Views
Post# 35624921

RE:RE:Curious enrollment spike pre raise...

RE:RE:Curious enrollment spike pre raise...Ha. Shill has got to shill.

Jan 12th announcement- 50 patients. So +22 over 8 months. 

And now you are calling Tigris' interim enrollment point of 60% - 80%?  I'm sure that news to all- including management.  You are also putting words in management's mouth that the 20% from the Euphrates trial "Exceeded Expectations". 

After tens of thousands of posts you're yet to be right on a single time table or a single evaluation. 


But shill on...
<< Previous
Bullboard Posts
Next >>